Stockreport

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Monotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Patient...

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Application Based on Overall Survival Data from Pivotal Phase 3 KEYNOTE-042 Trial KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known [Read more]